Health Care
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Latest
Report
The United States is currently grappling with a nursing shortage that is causing a ripple effect of rising health care costs and lower quality of life across the country.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Latest Content
This Coalition letter was sent to the Members of the House and Senate following recent efforts to keep ERISA pre-emption intact.
Whether it’s talking to clients on a couch—or walking on a scenic path—the owner of a therapy practice explains how mental health services can improve society.
Research shows workers and businesses value the employer-based health care benefit.
This Statement for the Record was sent to the Senate HELP Committee for the hearing, "The Need to Make Insulin Affordable for All Americans."
Support the health and well-being of millions of Americans—demand Congress reject proposals that threaten insulin innovation.
This Hill letter was sent to the Members of the Senate Committee on Health, Education, Labor and Pensions, on S. 1067, the "Ensuring Timely Access to Generics Act of 2023,” S. 1114, the “Expanding Access to Low-Cost Generics Act of 2023,” S. 1214, the “RARE Act,” and S. 1339, the “Pharmacy Benefit Manager Reform Act.”
This Statement for the Record was sent to the Members of the House Committee on Energy and Commerce, for the hearing, “Lowering Unaffordable Costs: Legislative Solutions to Increase Transparency and Competition in Health Care.”
Urge your member of Congress to protect American patients and stop this price control regime.
This Hill letter was sent to Members of the Senate Committee on Health, Education, Labor, and Pensions on its hearing entitled “Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?”
